国际皮肤性病学杂志    2001 27 (3): 160-163   ISSN: 2096-5540  CN: 32-1880/R   妊娠期间性传播疾病的处理 蒋明军综述1, 韩国柱审校2 1. 中国医学科学院皮肤病研究所; 2. 中国协和医科大学皮肤病研究所 收稿日期 null  修回日期 null  网络版发布日期 null 参考文献  [1] Donders GG.Treatment of sexually transmitted bacterial diseases in pregnant women.Drugs,2000,59(3):477-485. [2] Brocklehurst P.Update on the treatment of sexually transmitted infections in pregnancy-1.Int J STD AIDS,1999,10(9):571-580. [3] Centers for Disease Control and Prevention.Guidelines and treatment of sexually transmitted diseases:MMWR recommendations and report.Atlanta(GA):US Department of Health and Human Services,1998. [4] Alexander JM,Sheffield JS,Sanchez P J,et al.Efficacy of treatment for syphilis in pregnancy.Obstet Gynecol,1999,93(1):5-8. [5] Donders GG,Desmyter J,Hooft P,et al.Apparent failure of one injection of benzathine penicillin G for syphilis during pregnancy in human immunodeficiency virus-seronegative African women.Sex Transm Dis,1997,24(2):94-101. [6] Angela JR,Geoffrey LR.Concurrent gonococcal and chlamydial infection- how best to treat.Drugs,2000,59:801-813. [7] Brown ZA,Selke S,Zeh J,et al.The acquisition of herpes simplex virus during pregnancy.N Engl J Med,1997,337(8):509-515. [8] Smith JR,Cowan FM,Munday P.The management of herpes simplex virus infection in pregnancy.Br J Obstet Gynaecol,1998,105(3):255-260. [9] Nahmias A J,Josey WE,Naib ZM,et al.Perinatal risk associated with maternal genital herpes simplex virus infection.Am J Obstet Gynecol,1971,110(6):825-837. [10] Clinical Effectiveness Group.National guideline for the management of genital herpes.Sex Transm Infect,1999,75(Suppl 1):S24-S28. [11] Reiff-Eldridge R,Heffner CR,Ephross SA,et al.Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries:a pharmaceutical company commitment.Am J Obstet Gynecol,2000,182(1 Pt 1):159-163. [12] Brown Z,Hume RF,Selke S,et al.Subclinical shedding of herpes simplex virus at the time of labor.Presented at the annual meeting of the society of perinatal obstetricians.Miami Beach,FL,February 1998. [13] Brown ZA.Genital herpes complicating pregnancy.Dermatol Clin,1998,16(4):805-810. [14] Struthers BJ.Metronidazole appears not to be a human teratogen:review of the literature.Infect Dis Obstet Gynecol,1997,5:326-335. [15] Clinical Effectiveness Group.National guideline for the management of trichomonas vaginalis.Sex Transm Infect,1999,75(Suppl 1):S21-S23. [16] Clinical Effectiveness Group.National guideline for the management of bacterial vaginosis.Sex Transm Infect,1999,75(Suppl 1):S16-S18. [17] Hart G.Risk profiles and epidemiologic interrelationships of sexually transmitted diseases.Sex Transm Dis,1993,20(3):126-136. [18] McGregor JA,French JI.Bacterial vaginosis in pregnancy.Obstet Gynecol Surv,2000,55(5 Suppl 1):S1-S19. [19] Clinical Effectiveness Group.National guideline for the management of anogenital warts.Sex Transm Infect,1999,75(Suppl1):S71-S75. [20] Laboratory Centre for Disease Control.Canadian STD Guidelines.Ottawa:Health Canada,1998:191-200. 通讯作者: